Develops drugs for ovarian cancer and autoimmune diseases.
Jun 2026Revenue $450M/yrExpenses $714M/yr
No trendCash runway ≈ 4.4 years from Jun 2026
Figures by year
When will Zai Lab be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $450M and expenses $714M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $460M | $690M | −$229M |
| Dec 2024 | $399M | $681M | −$282M |
| Dec 2023 | $267M | $633M | −$367M |
| Dec 2022 | $215M | $619M | −$404M |
| Dec 2021 | $144M | $844M | −$700M |
| Dec 2020 | $49.0M | $351M | −$302M |
| Dec 2019 | $13.0M | $216M | −$203M |
| Dec 2018 | $129K | $142M | −$142M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.